Skip to main content
. 2023 Mar 2;102(4):819–827. doi: 10.1007/s00277-023-05142-4

Fig. 1.

Fig. 1

(A) Anti-SARS-CoV-2 S antibody titers at 3 months after the second vaccination in healthy controls and in patients with mature T/NK-cell neoplasms. (B) Anti-SARS-CoV-2 S antibody titers at 9 months after the second vaccination in healthy controls and patients with mature T/NK-cell neoplasms who received the booster vaccine or those who did not receive the booster vaccine. The Mann–Whitney U test was used to compare medians of antibody titers. The two short lines show interquartile range (IQR) and the center long line shows the median. HC, healthy controls